中国麻风皮肤病杂志 ›› 2026, Vol. 42 ›› Issue (7): 520-523.doi: 10.12144/zgmfskin202607520

• 临床研究 • 上一篇    下一篇

司库奇尤单抗治疗连续性肢端皮炎一例并文献复习

李明,李妍   

  1. 首都医科大学附属北京友谊医院皮肤科,北京,100050
  • 出版日期:2026-07-15 发布日期:2026-06-29

Acrodermatitis continua of hallopeau treated with secukinumab: a case report and literature review

LI Ming, LI Yan   

  1. Department of Dermatology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China
  • Online:2026-07-15 Published:2026-06-29

摘要: 本文报道司库奇尤单抗成功治疗连续性肢端皮炎1例。患者,女,18岁,左手手指红斑、脓疱2年余,既往口服阿维A、白芍总苷、阿普米司特,疗效欠佳。应用司库奇尤单抗治疗(第0、1、2、3、4周300 mg/次,后300 mg/4周皮下注射),治疗第3周,红斑基本消退;治疗第10个月,示指指甲完全正常,拇指指甲基本正常,甲周、甲下皮肤无异常。

关键词: 连续性肢端皮炎, 司库奇尤, 阿普米司特, 生物制剂

Abstract: This paper reports one case of successful treatment of acrodermatitis continua of hallopeau with secukinumab. The patient was an 18-year-old female with erythema and pustules on the fingers of the left hand for more than 2 years. Previous oral treatment with acitretin, total glucosides of paeony, and apremilast yielded poor efficacy. The patient received secukinumab therapy (300 mg per dose at weeks 0, 1, 2, 3 and 4, followed by subcutaneous injection of 300 mg every 4 weeks). At week 3 of treatment, the erythema almost completely resolved. At the 10th month of treatment, the index fingernail returned to normal completely, the thumb nail was nearly normal, and no abnormalities were observed in the periungual and subungual skin.

Key words: acrodermatitis continua of hallopeau, secukinumab, apremilast, biological agents